Among the identified 330 proteins with Kmal, IDH2 was also found to show a significant decrease of Kmal with enhanced enzymatic activity in cardiac hypertrophy (Fig. 4g).195 In the two studies above, it is consistent that upregulation of IDH2 activity in cardiomyopathy connects with disease progression. This evidence concerns the gene IDH2 and cardiac hypertrophy.